|
| Press Releases |
|
 |
|
| Monday, February 23, 2026 |
|
|
Bioxytran Initiates Research Collaboration with University of Georgia to Evaluate Drug Candidate's Ability to Block H5N1 Bird Flu Virus |
| Bioxytran, Inc. (OTCQB: BIXT), a clinical-stage biotechnology company developing breakthrough antiviral treatments, today announced it has initiated a research collaboration with the University of Georgia (UGA) as part of a $100M grant to explore the efficacy of its lead drug candidate in blocking the Highly Pathogenic Avian Influenza (HPAI) H5N1 virus, commonly known as bird flu. more info >> |
|
| Tuesday, February 17, 2026 |
|
|
Bioxytran, Inc. Announces Commercial Distribution Agreement with Khoury Medical LTD for A-SUQAR Dietary Supplement |
| Bioxytran, Inc., a biotechnology company developing galectin-targeting carbohydrate technologies with applications across infectious disease, metabolic health, and inflammation, today announced that it has entered into a commercial Distribution Agreement with Khoury Medical LTD ("Khoury Medical"), a company focused on the development and commercialization of plant-derived dietary supplements. more info >> |
|
| Wednesday, February 11, 2026 |
|
|
Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance with ProLectin-MBioxytran |
| Bioxytran, Inc. today announced positive clinical results from its recently completed Phase 2 randomized, double-blind, placebo-controlled, dose-optimization trial evaluating ProLectin-M in subjects with laboratory-confirmed acute viral infection. more info >> |
|
| Monday, February 2, 2026 |
|
|
Bioxytran and University of Minnesota Launch Sponsored Research Collaboration to Advance Novel Carbohydrate-Based Therapeutics |
| Bioxytran, Inc., a clinical-stage biotechnology company developing platform technologies spanning glycovirology, hypoxia, and degenerative diseases, announced the execution of a Sponsored Research Agreement with the University of Minnesota to support advanced biochemical research aimed at improving the understanding and development of novel polysaccharide and oligosaccharide interactions with biologically relevant targets. more info >> |
|
| Thursday, January 29, 2026 |
|
|
Bioxytran Provides Corporate Update Highlighting Momentum Across Its Multi-Platform Pipeline |
| Bioxytran, Inc. (OTCQB: BIXT) ("Bioxytran" or the "Company"), a clinical-stage biotechnology company developing platform technologies spanning glycovirology, hypoxia, and degenerative diseases, today issued a corporate update summarizing previously disclosed program developments and reinforcing the Company's strategic direction entering 2026. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
GMG's THERMAL-XR(R) to be Applied Exclusively & Distributed to Global Oil and Gas/LNG Industry with Curran International
May 19, 2026 20:29 HKT/SGT
|
|
|
'Young at Heart' 3DG Jewellery Brand Tour Kicks Off in Wuhan
May 19, 2026 20:10 HKT/SGT
|
|
|
Kincora Receives Option Payment for Divestment of Mongolian Assets
May 19, 2026 17:59 HKT/SGT
|
|
|
「Young at Heart 心齡無界」金至尊珠寶品牌巡展首站於武漢璀璨啟幕
May 19, 2026 15:44 HKT/SGT
|
|
|
「Young at Heart 心龄无界」金至尊珠宝品牌巡展首站于武汉璀璨启幕
May 19, 2026 15:44 HKT/SGT
|
|
|
Carbonverse打造「碳資產+數字錢包+使用即挖礦」新生態
May 19, 2026 15:41 HKT/SGT
|
|
|
Vaiz introduces agile project management tools as teams leave Jira for simpler alternatives
May 19, 2026 15:00: JST
|
|
|
Vaiz introduces agile project management tools as teams leave Jira for simpler alternatives
May 19, 2026 14:00 HKT/SGT
|
|
|
SMBC Group, Fujitsu and SoftBank agree on alliance to build Japan-made platform for sustainable healthcare
May 19, 2026 13:37 JST
|
|
|
SMBCグループ、富士通、ソフトバンク、健康・医療分野での業務提携に合意し、持続可能な医療の実現に向けて国産ヘルスケア基盤を構築
May 19, 2026 11:15: JST
|
|
|
Anson Resources Engineering Study Confirms Green River as a Future Low-Cost Producer
May 19, 2026 10:40 HKT/SGT
|
|
|
'Hong Kong Cinema @ CANNES 2026': Hong Kong's role as a bridge between global and Asian film markets
May 19, 2026 10:16 HKT/SGT
|
|
|
宇樹科技、雲深處IPO進程提速 首程控股（697.HK）機器人投資進入價值驗證期
May 19, 2026 09:05 HKT/SGT
|
|
|
Unitree Robotics and DEEP Robotics Accelerate IPO Progress; Shoucheng Holdings' Robotics Investments Enter a Value Validation Phase
May 19, 2026 08:58 HKT/SGT
|
|
|
Shoucheng Holdings (697.HK): Robotics Investments Near Monetization Window as Dividends and Buybacks Strengthen Shareholder Returns
May 19, 2026 08:52 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
